Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 9/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.35 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.35 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.35 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 2/20 | 0.34 |
| ▸ | IKBKB | O14920 | 1/20 | 0.34 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.34 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.34 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | RET | P07949 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27074407 | 0.86 | CSNK2A1 (0.46) | JAK2CHEK1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL27074410 | 0.86 | LATS1 (0.42) | JAK2CHEK1ZAP70JAK1MAPK1 | |
| SCHEMBL27074406 | 0.83 | IDO1 (0.42) | JAK2CHEK1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL27075669 | 0.82 | JAK2 (0.40) | JAK2TGFBR1ZAP70PIK3C3 | |
| SCHEMBL27074405 | 0.82 | PIM1 (0.52) | CHEK1CSNK2A2CSNK2BCSNK2A1PIM1 | |
| SCHEMBL27074419 | 0.82 | PIM1 (0.50) | CHEK1CSNK2A2CSNK2BCSNK2A1PIM1 | |
| SCHEMBL27074418 | 0.82 | ABCG2 (0.43) | JAK2CHEK1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL27074404 | 0.82 | JAK2 (0.48) | JAK2CHEK1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL27074411 | 0.81 | LATS1 (0.45) | JAK2PIM1KDRPIM2 | |
| SCHEMBL27074414 | 0.81 | KDM1A (0.39) | JAK2CHEK1ZAP70JAK1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11884670-B1 | Pyrido[4′,3′:4,5]pyrrolo[3,2-c][2,7]naphthyridin-10-one compounds as CK2 inhibitors | King Faisal University (SA) | 2024-01-30 | — | — | US | claimed |
| US-11884670-B1 | Pyrido[4′,3′:4,5]pyrrolo[3,2-c][2,7]naphthyridin-10-one compounds as CK2 inhibitors | King Faisal University (SA) | 2024-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11884670-B1 | Pyrido[4′,3′:4,5]pyrrolo[3,2-c][2,7]naphthyridin-10-one compounds as CK2 inhibitors | CKS2, CDK2, PNKP | JAK2 73/4885CHEK1 231/4885TGFBR1 3004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.